Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
Financial Results:
Alkem Laboratories Ltd reported Revenues for Q4FY25 of ₹3,144.00 Crores up from ₹2,936.00 Crore year on year, a rise of 7.08%.
Total Expenses for Q4FY25 of ₹2,892.00 Crores up from ₹2,644.00 Crores year on year, a rise of 9.38%.
Consolidated Net Profit of ₹322.00 Crores up 5.92% from ₹304.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹25.58, up 4.20% from ₹24.55 in the same quarter of the previous year.